DO SPECIFIC ACPAS OR OTHER AUTOANTIBODIES MEASURED BY A NOVEL ASSAY PREDICT RESPONSE TO METHOTREXATE MONOTHERAPY IN PATIENTS WITH EARLY DMARD-NAIVE RA?